Most read article(s)

You have access
Protocol-Dependent Differences in IC₅₀ Values Measured in Human Ether-Á-Go-Go–Related Gene Assays Occur in a Predictable Way and Can Be Used to Quantify State Preference of Drug Binding
William Lee, Monique J. Windley, Matthew D. Perry, Jamie I. Vandenberg and Adam P. Hill

Molecular Pharmacology May 2019, 95 (5) 537-550; DOI: https://doi.org/10.1124/mol.118.115220
You have access
Opioid pharmacology under the microscope
Damien Jullié, Arisbel B Gondin, Mark E Von Zastrow and Meritxell Canals

Molecular Pharmacology April 10, 2020, mol.119.119321; DOI: https://doi.org/10.1124/mol.119.119321
You have access
Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology
Rachael R. Schulte and Richard H. Ho

Molecular Pharmacology May 2019, 95 (5) 490-506; DOI: https://doi.org/10.1124/mol.118.114314
You have access
Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and β-Arrestin
Christina M.G. Vanderboor, Pierre E. Thibeault, Kevin C.J. Nixon, Robert Gros, Jamie Kramer and Rithwik Ramachandran

Molecular Pharmacology June 2020, 97 (6) 365-376; DOI: https://doi.org/10.1124/mol.119.118232
You have access
Lysosome Membrane Permeabilization and Disruption of the Molecular Target of Rapamycin (mTOR)-Lysosome Interaction Are Associated with the Inhibition of Lung Cancer Cell Proliferation by a Chloroquinoline Analog
Juan Sironi, Evelyn Aranda, Lars Ulrik Nordstrøm and Edward L. Schwartz

Molecular Pharmacology January 2019, 95 (1) 127-138; DOI: https://doi.org/10.1124/mol.118.113118
Open Access
Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann

Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
You have access
Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2
Ilya S. Senatorov, Ameneh Cheshmehkani, Rebecca N. Burns, Kirti Singh and Nader H. Moniri

Molecular Pharmacology May 2020, 97 (5) 304-313; DOI: https://doi.org/10.1124/mol.119.117697
You have access
The Pharmacology and Function of Receptors for Short-Chain Fatty Acids
Daniele Bolognini, Andrew B. Tobin, Graeme Milligan and Catherine E. Moss

Molecular Pharmacology March 2016, 89 (3) 388-398; DOI: https://doi.org/10.1124/mol.115.102301
You have access
A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor
Renee A. Bouley, Zara Y. Weinberg, Helen V. Waldschmidt, Yu-Chen Yen, Scott D. Larsen, Manojkumar A. Puthenveedu and John J.G. Tesmer

Molecular Pharmacology June 2020, 97 (6) 392-401; DOI: https://doi.org/10.1124/mol.119.118661
Open Access
Neutral Diclofenac Causes Remarkable Changes in Phosphatidylcholine Bilayers: Relevance for Gastric Toxicity Mechanisms
Catarina Pereira-Leite, Sarah K. Jamal, João P. Almeida, Ana Coutinho, Manuel Prieto, Iolanda M. Cuccovia, Cláudia Nunes and Salette Reis

Molecular Pharmacology April 2020, 97 (4) 295-303; DOI: https://doi.org/10.1124/mol.119.118299

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals